AI Metaverse Rank 4739
$0.004103
AI Metaverse Rank 4739
Website Twitter
0 AIM

AI Metaverse
AI Metaverse
AIM

AI Metaverse Price
$ 0.0041

AI Metaverse 24h Vol
$26,486

AI Metaverse Market Cap
$0

24h Vol
168,688,381 BTC
1 H
0.01 %
24 H
5.12 %
7 d
6.28 %
Today AI Metaverse price in US dollars is currently 0.0041 USD, and if converted to Bitcoin is 26.13 BTC. A total of N/A are currently circulating in the Market. AI Metaverse price is currently experiencing a change of 5.12 %, and check here all cryptocurrency. Over the past 24 hours 0.000 M US dollars AI Metaverse have been traded on Crypto Exchanges. Get AI Metaverse's progress by adding it to your favourites and creating a free portfolio.
Full Name
AI Metaverse
Symbol
AIM
Algorithm
BTC Price
26.13 BTC
BTC Market
0 BTC
BTC 24h Vol
168,688,381 BTC
Total Coins Mined
0 AIM
1h
0.01 %
24h
5.12 %
7d
6.28 %
Share AI Metaverse Price



Description

Description


Aimedis is a medical care platform. It works as an intermediary between doctors and patients in order to create a medical data marketplace, where users can provide medical data to the doctors, and doctors can diagnose patients. At Aimedis, online medical prescriptions are possible as well as access to A.I. (Artificial Intelligence) tools that are able to examine medical data.

The Aimedis (AIM) token is an Ethereum-based (ERC-20) cryptocurrency. It will serve the users as a medium to exchange value between them and/or to pay for other users medical services when using Aimedis. In addition, to buy or sell medical data, AIM tokens are required.

ICO Details

ICO Details


)

Aimedis is a medical care platform. It works as an intermediary between doctors and patients in order to create a medical data marketplace, where users can provide medical data to the doctors, and doctors can diagnose patients. At Aimedis, online medical prescriptions are possible as well as access to A.I. (Artificial Intelligence) tools that are able to examine medical data.

The Aimedis (AIM) token is an Ethereum-based (ERC-20) cryptocurrency. It will serve the users as a medium to exchange value between them and/or to pay for other users medical services when using Aimedis. In addition, to buy or sell medical data, AIM tokens are required.

Team:

  • Dr. Michael J. Kaldasch: CEO, MD & founder. 
  • Dr. Ben El Idrissi: COO, MD & founder. 
  • Sankar Ghanesh: CTO. 
  • Dr. Lazaros Fountoukidis: CMO & MD. 

Aimedis ICO will begin on TBA. The ICO token supply represents 50% of the total token supply, so there is a total of 300,000,000 AIM tokens available, for 0.12 USD each. The ICO funding target is 9,000,000 USD, the funding cap is 36,000,000 USD and is expected to end on TBA or when the funding cap is reached.

Token Reserve Split (50%):

  • 20% Community initiatives, marketing & legal;
  • 20% Team, supporters & advisory board;
  • 5% Legal reserve;
  • 5% Reserve.

Aimedis ICO features a bonus of 20% upon the Pre-Sale.

 

ICO Status Upcoming
Token Supply 600000000
Start Date N/A
End Date N/A
Fund Raised (BTC) N/A
Fund Raised (USD) N/A
Start Price (USD) 0.12
Security Audit Company N/A
ICO Legal Form Corporation
ICO Jurisdiction Netherlands
Legal Advisers N/A
Blog https://medium.com/@aimedisglobal
White Paper https://aim.aimedis.com/pdf/WhitepaperEN10.pdf

Get Crypto Newsletter
Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.